Antiepileptic drugs and suicide-related behavior: Is it the drug or comorbidity?

Neurology. Clinical Practice
Hari K Raju SagirajuMary Jo V Pugh

Abstract

We sought to compare trends of suicide-related behavior (SRB) before and after initiation of antiepileptic drug (AED) therapy among AED users (with and without epilepsy) to that of individuals without AED use controlling for sociodemographic characteristics and mental health comorbidity. We used national Veterans Health Administration (VHA) data for post-9/11 veterans who received VHA care (2013-2014) without prior AED use. We conducted generalized estimation equation (GEE) analyses, stratified by epilepsy status and type of AED received, to assess the trend of SRB prevalence the year prior to and after the index date (date of first AED prescription/date of first health care encounter for non-AED users) controlling for sociodemographic factors and mental health comorbidity. The GEE analysis showed significant curvilinear trends of SRB prevalence over the 24-month study period among the AED users, indicating that the probability of SRB diagnoses increased over time with a peak before the index month and decreased thereafter. Similar patterns were observed among non-AED users, but significantly lower odds for SRB. Among AED users, there were no significant differences by epilepsy status; however, higher SRB prevalence and differe...Continue Reading

References

Aug 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R W SchrierJ H Sadler
Jan 1, 1995·International Psychogeriatrics·Y Conwell, D Brent
Sep 10, 2003·Neurology·M MulaJ W A S Sander
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Jun 16, 2004·Archives of Internal Medicine·David N JuurlinkDonald A Redelmeier
Aug 4, 2004·The Journal of Ambulatory Care Management·Alfredo J SelimLewis E Kazis
Sep 22, 2005·Epilepsy Currents·Siddhartha Nadkarni, Orrin Devinsky
Nov 24, 2005·Epilepsia·Mary Jo V PughLewis E Kazis
Jan 5, 2006·The American Journal of Psychiatry·Gregory E SimonPhilip S Wang
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alan B Ettinger, Charles E Argoff
Jun 15, 2007·Journal of Epidemiology and Community Health·Mark S KaplanJason T Newsom
Jul 6, 2007·Lancet Neurology·Jakob ChristensenEsben Agerbo
Jun 6, 2009·Epilepsia·Dale C Hesdorffer, Andres M Kanner
Jun 18, 2009·Current Opinion in Neurology·Gail S Bell, Josemir W Sander
Apr 15, 2010·JAMA : the Journal of the American Medical Association·Elisabetta PatornoSebastian Schneeweiss
Jan 29, 2011·Seizure : the Journal of the British Epilepsy Association·René Andrade MachadoYaima Quintana Rodríguez
Jan 1, 2010·Drug, Healthcare and Patient Safety·Jeffery W Britton, Jerry J Shih
Mar 10, 2012·Journal of Psychopharmacology·Konstantinos N FountoulakisApostolos Iacovides
Jan 10, 2014·Neuroepidemiology·Pili FerrerLuisa Ibáñez
Apr 4, 2014·The Journal of Head Trauma Rehabilitation·Mary Jo V PughJordan H Grafman
Jul 24, 2014·Epilepsia·Nicholas MeyerKeith Hawton
Apr 26, 2015·Epilepsy & Behavior : E&B·Natalie N RohdeMary Jo Pugh
Jul 19, 2015·The International Journal of Neuropsychopharmacology·Fabian TermorshuizenEibert R Heerdink
Dec 10, 2015·JAMA Psychiatry·Dale C HesdorfferW Allen Hauser
Nov 11, 2016·MMWR. Morbidity and Mortality Weekly Report·Mary Jo PughRosemarie Kobau
Jan 5, 2017·Pharmacoepidemiology and Drug Safety·Lamiae Grimaldi-BensoudaUNKNOWN PROTECT-WP6 study group

❮ Previous
Next ❯

Citations

Apr 9, 2021·International Journal of Clinical Practice·Sai Krishna Gudi, Qaiser Jahan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.